Astellas Pharma Global Development, Inc.
Clinical trials sponsored by Astellas Pharma Global Development, Inc., explained in plain language.
-
New cancer drug trial targets Hard-to-Treat tumors
Disease control Not yet recruitingThis study is testing a new drug called ASP546C for people with advanced stomach, pancreatic, and other cancers that have spread or cannot be removed by surgery. The main goals are to find a safe dose and see if the drug can shrink tumors. About 150 participants will receive the …
Phase: PHASE1, PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Apr 01, 2026 23:11 UTC
-
New hope to save bladders from cancer surgery
Disease control Not yet recruitingThis study is testing whether a combination of two drugs, enfortumab vedotin and pembrolizumab, can effectively treat muscle-invasive bladder cancer so patients can keep their bladder. The goal is to see how many people have their cancer disappear and how many still have their bl…
Phase: PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Scientists track vision loss in rare eye disease
Knowledge-focused Not yet recruitingThis study aims to understand how vision changes over time in people with Stargardt disease and similar inherited eye conditions that cause central vision loss. Researchers will observe 90 participants for up to 2 years, tracking their vision with standard eye tests every 6 month…
Sponsor: Astellas Pharma Global Development, Inc. • Aim: Knowledge-focused
Last updated Mar 02, 2026 15:28 UTC